HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)

Syndrome characterized by the triad of oculocutaneous albinism (ALBINISM, OCULOCUTANEOUS); PLATELET STORAGE POOL DEFICIENCY; and lysosomal accumulation of ceroid lipofuscin.
Also Known As:
Hermansky-Pudlak Syndrome; Hermanski Pudlak Syndrome; Hermansky Pudlak Syndrome
Networked: 241 relevant articles (2 outcomes, 13 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Lung Diseases (Lung Disease)
2. Oculocutaneous Albinism (Albinism, Yellow Mutant)
3. Pulmonary Fibrosis (Fibrosing Alveolitis)
4. Schizophrenia (Dementia Praecox)
5. Vitiligo

Experts

1. Gahl, William A: 16 articles (01/2018 - 02/2002)
2. Gochuico, Bernadette R: 10 articles (06/2022 - 06/2011)
3. Li, Wei: 10 articles (01/2021 - 03/2002)
4. Dell'Angelica, Esteban C: 9 articles (05/2010 - 07/2003)
5. Huizing, Marjan: 7 articles (08/2012 - 02/2002)
6. Suzuki, Tamio: 6 articles (06/2022 - 03/2002)
7. Swank, Richard T: 6 articles (07/2005 - 03/2002)
8. O'Brien, Kevin J: 4 articles (01/2018 - 01/2016)
9. Boissy, Raymond E: 4 articles (06/2007 - 01/2005)
10. Gautam, Rashi: 4 articles (03/2004 - 07/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hermanski-Pudlak Syndrome:
1. Serotonin (5 Hydroxytryptamine)IBA
07/15/1988 - "An improved method for measuring endogenous serotonin in platelets of patients with Hermansky-Pudlak syndrome."
04/01/2011 - "Furthermore, this electrochemical method was applied to study the stimulation-secretion coupling in platelets, serotonin storage and release dynamics with applied pharmacological agents, and chemical messenger storage deficiency in Hermansky-Pudlak Syndrome (HPS) platelets, and the potential of this method to reveal secretion behavior in both normal and diseased platelets has clearly been demonstrated."
01/01/1982 - "The Hermansky-Pudlak syndrome is a mild bleeding disorder in which the platelets are markedly deficient in the storage pool of adenine nucleotides and serotonin. "
02/01/1997 - "In the presence and absence of extracellular calcium, the [Ca2+]i response induced by 10 microM ADP, but not those induced by 0.1 unit/ml thrombin, 3.3 microM U46619, or 20 microM serotonin, was significantly greater in SPD platelets than in normal platelets, and was increased to the greatest extent in SPD patients with Hermansky-Pudlak syndrome (HPS), in whom the dense granule deficiencies are the most severe. "
01/01/1976 - "The authors have examined 8 cases with Hermansky-Pudlak syndrome in whom besides the usual abnormalities of abnormal aggregation with collagen, absence of second wave of aggregation, reduction of the 5-HT uptake, presence of 5-HIAA in the platelets, two new abnormalities are described: the presence of a large amount of an unidentified metabolite after 5-HT incorporation which differs from 5-HT and 5 hydroxytryptophol and an abnormal incorporation of labelled glycerol in the triglycerides. "
2. CalciumIBA
3. Adenosine Diphosphate (ADP)IBA
4. 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA
5. ThrombinFDA Link
6. CeroidIBA
7. Proteins (Proteins, Gene)FDA Link
8. Melanins (Melanin)IBA
9. pirfenidoneIBA
10. Biomarkers (Surrogate Marker)IBA

Therapies and Procedures

1. Lung Transplantation
2. Therapeutics
3. Platelet Transfusion (Blood Platelet Transfusions)
4. Vaginal Birth after Cesarean
5. Extracorporeal Membrane Oxygenation